About us

Your trusted end-to-end CDMO partner

Find out more

Who we are 

We’re India’s first specialty pharma pure-play CDMO.

With three decades of experience in specialized drug development and manufacturing, we are able to consistently deliver comprehensive solutions efficiently and effectively across various technology platforms and therapeutic modalities.

Our team of over 1,200 professionals, including more than 200 techno-commercial experts has one goal – to work closely with our partners and make their vision come to life.

We’re here to change the way you think about CDMOs. So, while others might stand in your way, we deliver your ambitions with agility and flexibility. Why? Because your success is our success.

So here we are, the type of CDMO you didn’t know could possibly exist.

What we do

Drug-device combinations 

We have over 30 years of experience in developing drug-device combinations. Our multi-disciplinary team can solve any design, compatibility, device interaction and stability challenges that arise during the development and manufacturing process. We specialize in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors.

Complex injectables 

With over 25 years of domain experience in sterile injectables, we can leverage our deep expertise in formulation and analytical development, all the way to optimization, scale-up and transfer of lyophilization cycles.

Biologics 

Our integrated services offer comprehensive biologics solutions – all under one roof. We can support the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and RNA products.

Soft gelatin capsules 

We are masters in a spectrum of soft gelatin capsule technologies. This means that we can cater to a variety of capsule shapes and sizes, as well as innovative formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps and suppositories.

Explore our capabilities

Capabilities

Our journey  

OneSource, a Strides Pharma initiative, has a strong legacy of manufacturing excellence in the pharmaceutical and biotechnology industries.

Our values

Integrity

We adhere to ethical practices and maintain transparency in our conduct, fostering a culture of trust and integrity in the organisation.

Competency

We develop and effectively apply our knowledge, abilities and skills to successfully and consistently deliver desired outcomes.

Efficiency

We are agile and collaborative to deliver quicker and better results.

Not just another pharmaceutical CDMO

Contact our team

End-to-end services across multiple modalities

From early stage development to commercialization and lifecycle management, we can advise and deliver on all your unique requirements, taking care of the complexities, all under one roof. So you don’t have to.

Customer-first. Always.

We’re reliable, transparent and fast. We will do whatever it takes to solve your challenges. Our dedicated tech transfer and project management teams are agile, efficient and will work with you in full transparency.

Unique breadth of technical expertise

Our technical expertise is second to none. We’re experts in every discipline we work in across multiple drug product formats and drug substance technologies, with proven track record and legacy in formulation, drug-devices and oral technologies.

Robust quality and compliance standards

Quality, compliance and confidentiality are a non-negotiable for us – in everything we do. From our regulatory approved facilities to robust Quality Management Systems (QMS) and track record of 18 successful inspections in the last 24 months.

State-of-the-art facilities: A blueprint for success

When it comes to our facilities, there is no room for compromise. That’s why our cutting-edge development and manufacturing sites are equipped with the latest technology and highest standards. Approved by various regulatory bodies, including the FDA, MHRA, ANVISA, TGA, WHO and MCC, our facilities speak for our commitment to excellence.

We currently operate five state-of-the-art facilities in Bengaluru, India, with plans for future expansion coming soon.

Leadership team

Neeraj Sharma

CEO & Managing Director

Neeraj Sharma

CEO & Managing Director

In a distinguished career spanning of 28 years, Neeraj has resided and worked in pharma markets in India, South-East Asia, Latin America, and Europe. A seasoned professional, Neeraj has extensive General Management and P&L experience, steering businesses through pivotal stages such as market entry, growth leadership, turnarounds and M&A integration. His experience encompasses both highly regulated and emerging markets, providing him with a discerning perspective on the pharmaceutical industry. Neeraj brings a wealth of experience to his role as Managing Director at OneSource. 
 
Neeraj has been an integral part of the group for nearly 3 years (2021-24), overseeing the sterile injectable business – Steriscience, the Promoter entity. His strategic vision and leadership have contributed significantly to streamlining operations and driving growth within the organization. 
 
In his previous role as the Head of Generics Business for Western Europe for Sun Pharma, Neeraj successfully spearheaded the establishment of a significant sterile injectables business in Europe, including numerous pioneering ready-to-use products. 
 
Outside of work, Neeraj indulges in his favorite activities, including reading, working out and delving into the intricacies of Urdu poetry. 

Anurag Bhagania

Chief Financial Officer

Anurag Bhagania

Chief Financial Officer

Anurag Bhagania brings with him over 25 years of extensive experience, including the last decade serving as CFO of publicly listed companies. With a background as a Chartered Accountant and an MBA in Marketing, he is focused on enhancing stakeholder wealth through transformational growth initiatives. 
 
Anurag has hands-on experience across various manufacturing industries and a wide range of finance functions. His approach focuses on driving performance, simplifying processes, improving productivity, and fostering excellence through a people-oriented and goal-focused methodology. 
 
Prior to joining OneSource, Anurag held the position of CFO at Kirloskar Oil Engines. In the past, he has worked with large global automotive and industrial manufacturing companies like SKF, Honeywell, General Electric, and others. 
 
Anurag enjoys racquet sports such as badminton and squash and travel during his free time. 

Jason Spacek

Chief Business Officer

Jason Spacek

Chief Business Officer

Jason Spacek brings over two decades of leadership experience in the pharmaceutical and biotech industries, combining strategic acumen with operational expertise. As Chief Business Officer at OneSource, Jason drives the company’s growth initiatives and strengthens partnerships across global markets.

With a proven track record in business development, operational management, and market strategy, Jason has held senior leadership roles at prominent organizations, including Catalent Pharma Solutions, Alcami Corporation, and Lonza. His expertise spans P&L management, market analysis, and assembling high-performing teams to achieve transformative results.

Jason holds a Bachelor of Science in Microbiology from the University of Maryland and a Master of Science in Cell and Molecular Biology from Towson University. Based in North Carolina, USA, he is passionate about fostering innovation and delivering tailored solutions to meet the evolving needs of the healthcare sector.

Prateek Gupta

SVP & Head – Technical Development

Prateek Gupta

SVP & Head – Technical Development

Prateek provides overall leadership for delivering high-value biopharmaceutical development services for our global customers and he is responsible for designing and driving process development strategy in line with the OneSource vision. Prateek possesses tremendous technical acumen, leadership and organizational building abilities. 
 
Prateek has over 13 years of industry experience, including international leadership roles in biopharmaceutical companies and academic institutions, including significant experience in the development of biomolecules for better health. Prior to OneSource, Prateek was the Senior General Manager and Head of Process Science, R&D at Intas Pharmaceuticals, where he was responsible for the overall technical and operational strategy for the development of cell lines and processes for the company’s biosimilar portfolio. Prateek previously served in increasingly responsible roles in Pfizer, Total Energies and Genentech. 
 
Prateek has an exceptional educational pedigree with a PhD in Chemical and Biomolecular Engineering from Cornell University and a dual degree (B. Tech and M. Tech) from Indian Institute of Technology, Delhi in Biochemical Engineering and Biotechnology. 

Murari Madhab Mishra

Chief Human Resources Officer

Murari Madhab Mishra

Chief Human Resources Officer

Madhab is an M.Sc. (Chemistry), an MBA (XIMB), and an MA (Psychology). He comes with over 19 years of experience working in pharmaceutical, energy and digital technology sectors. Madhab has worked with Dr. Reddy’s and Reliance Jio apart from an entrepreneurial stint with his start up. He was CHRO for Steriscience, a group company, for 2 years before taking up the additional responsibility of OneSource in 2023. He brings with him extensive domain expertise in organization design, talent management, leadership development, succession management, compensation & benefits and business partnering. He has worked in and for markets of ASEAN, Central Asia, EU & the Americas. He has designed and executed psychometric assessments for 13000+ participants with a 65% validity and 95% reliability scores helping stakeholders find the right successor for 2000+ jobs. He is a polyglot and has diverse hobbies. 

Biju Mathew

Chief Operating Officer

Biju Mathew

Chief Operating Officer

Biju Mathew serves as the Chief Operating Officer at OneSource, bringing over 28 years of extensive expertise in managing quality systems and regulatory compliance for the pharmaceutical industry. A pharmacist from Bangalore University, Biju has led successful audits and inspections with global regulatory agencies, including USFDA, MHRA, ANVISA, and TGA. 

An integral part of the group, Biju joined Steriscience in November 2020 after a notable tenure at Stelis Biopharma, where he served as Head of Quality and sat on the Board of Directors. At Stelis, he was instrumental in establishing a state-of-the-art drug product and drug substance manufacturing facility, along with implementing a sustainable, robust Quality System that meets stringent global regulatory standards. Prior to his work with Stelis, Biju was Head of Quality at Wockhardt Bio Pharma, where he oversaw the commissioning, qualification, and development of Quality Systems for a large-scale drug substance microbial block, helping to secure various regulatory approvals. 

Earlier in his career, Biju spent 19 years in quality roles with Strides/Agila Specialties (injectables division) and later at Mylan as Head of Quality, where he played a pivotal role in securing multiple global regulatory approvals. 

Outside of work, Biju enjoys reading, watching movies, and engaging in various sports. 

Ravi Kumar

Head – Corporate strategy and operational excellence

Ravi Kumar

Head – Corporate strategy and operational excellence

Ravi heads corporate strategy at OneSource spanning all aspects of the business. He has played a key role in formulating the OneSource strategy post-merger of 3 businesses. He also manages the IP-led CDMO business for sterile injectables. 

Ravi has over 17 years of industry and consulting experience around the globe. Prior to OneSource, he was heading corporate strategy, M&A and portfolio for Xellia Pharmaceuticals at their corporate headquarter in Copenhagen, Denmark and was instrumental in building an innovative pipeline for the business. He also ran the divestment process for Xellia. He was also instrumental in turning around the anti-infectives business at Sandoz during the 2 years he spent at their corporate headquarters in Munich. As a management consultant with Kearney, he delivered several growth and transformational projects for Pharma, Chemicals and FMCG companies. 

Ravi holds an MBA degree from IIM Ahmedabad and a B tech. in Mechanical engineering degree from IIT Kanpur. 

Advisory team

Dr. Claudio Albrecht

Dr. Albrecht, with a Ph.D. in Law, has 30+ years in pharma. He started at Sandoz in 1987, led Ratiopharm Group’s growth as CEO, co-founded CoMeth, and oversaw Actavis Group’s $6 billion sale to Watson. He also co-founded Albrecht, Prock & Partners AG and was CEO of STADA AG until 2018.

Carl-Åke Carlsson

Mr. Carlsson, with over 30 years in the pharmaceutical industry, has a strong Scandinavian background. Born in Norway with Swedish roots and having worked in Denmark, he led Xellia Pharmaceuticals as CEO for 15 years, growing the company to $300 million in annual sales and managing 1,800 employees.

Dr. Rashmi H Barbhaiya

Dr. Barbhaiya, is a pharmaceutical executive with global experience. He spent 21 years at Bristol-Myers Squibb, then became President of R&D at Ranbaxy, where he developed a novel anti-malarial drug. In 2005, he co-founded Advinus Therapeutics, integrating drug discovery with pre-clinical development to boost R&D productivity.

Dr. Aleksandar Danilovski (Sasa)

Dr. Danilovski, with nearly 30 years in pharma, is the founder of DALISCO d.o.o. and advises companies in Europe and the U.S. He has been Chief Scientific Officer at Xellia Pharmaceuticals, VP of European R&D at Barr Laboratories, and on the Management Board at PLIVA Pharmaceuticals.

Dr. Aqeel A. Fatmi

Dr. Fatmi, with over 40 years in pharma, retired in 2016 as Chief Science Officer at Patheon. He co-founded the Georgia Combinatorial Chemistry Center and held senior roles at Solvay Pharmaceuticals. He also serves on the University of Georgia’s School of Pharmacy advisory board.

Our responsibility

Environmental, Social and Governance (ESG) standards

We put the planet and its people first. At our manufacturing sites, 78% of our energy needs are already met by renewable sources like solar and wind power. But we’re not stopping there. We have targets in place to achieve: 

  • 90% renewable energy by 2026 
  • 100% renewable energy by 2030 

To further reduce our environmental footprint, we’re using LPG in our boiler systems to lower carbon emissions, and we’ve adopted water recycling and desilication processes to maximize water recovery and minimize raw water usage. 

But sustainability isn’t just about the environment. We’re deeply invested in uplifting the communities where we operate, such as in Doddaballapur, India. From installing water plants to improving local schools, we take action to support and develop these communities.  It’s not just our Corporate Social Responsibility (CSR) – it’s our commitment to creating lasting positive impact. 

Discover a partnership where you and your ideas come first

Contact us